Advertisement
Screener

PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) Scorecard

2.8 / 5 stars · 68/120 Roast Me

PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) Scorecard

  • 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
  • 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
  • 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
  • 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
19/120 All 120 Win/Lose results shown below

Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

QuarterTotal returnRevenue growthEPS growth
2026-Q21/3 WinPVCT / S&P
35.29% / 15.20%
LosePVCT / S&P
PVCT unavailable / 15.00%
LosePVCT / S&P
PVCT unavailable / 50.40%
2026-Q10/3 LosePVCT / S&P
-8.93% / -4.33%
LosePVCT / S&P
PVCT unavailable / 11.30%
LosePVCT / S&P
PVCT unavailable / 27.70%
2025-Q40/3 LosePVCT / S&P
-37.08% / 2.65%
LosePVCT / S&P
PVCT unavailable / 9.00%
LosePVCT / S&P
PVCT unavailable / 13.40%
2025-Q31/3 WinPVCT / S&P
18.67% / 8.12%
LosePVCT / S&P
PVCT unavailable / 4.61%
LosePVCT / S&P
PVCT unavailable / 13.45%
2025-Q20/3 LosePVCT / S&P
-25.00% / 10.94%
LosePVCT / S&P
-32.71% / 4.83%
LosePVCT / S&P
PVCT unavailable / 10.63%
2025-Q11/3 LosePVCT / S&P
-16.67% / -4.27%
WinPVCT / S&P
11.33% / 4.98%
LosePVCT / S&P
PVCT unavailable / 10.57%
2024-Q42/3 WinPVCT / S&P
22.45% / 2.41%
WinPVCT / S&P
10.66% / 5.25%
LosePVCT / S&P
PVCT unavailable / 6.15%
2024-Q31/3 LosePVCT / S&P
-22.22% / 5.89%
WinPVCT / S&P
20.36% / 5.89%
LosePVCT / S&P
PVCT unavailable / 6.11%
2024-Q20/3 LosePVCT / S&P
-31.15% / 4.28%
LosePVCT / S&P
-19.22% / 5.38%
LosePVCT / S&P
PVCT unavailable / 5.12%
2024-Q11/3 WinPVCT / S&P
90.63% / 10.56%
LosePVCT / S&P
-41.30% / 5.71%
LosePVCT / S&P
PVCT unavailable / 5.59%
2023-Q41/3 WinPVCT / S&P
12.94% / 11.69%
LosePVCT / S&P
-43.61% / 6.81%
LosePVCT / S&P
PVCT unavailable / 7.78%
2023-Q30/3 LosePVCT / S&P
-24.78% / -3.27%
LosePVCT / S&P
PVCT unavailable / 7.52%
LosePVCT / S&P
PVCT unavailable / -5.03%
2023-Q20/3 LosePVCT / S&P
-31.52% / 8.74%
LosePVCT / S&P
PVCT unavailable / 9.50%
LosePVCT / S&P
PVCT unavailable / -8.57%
2023-Q11/3 WinPVCT / S&P
52.78% / 7.50%
LosePVCT / S&P
PVCT unavailable / 10.77%
LosePVCT / S&P
PVCT unavailable / -15.69%
2022-Q41/3 WinPVCT / S&P
120.41% / 7.56%
LosePVCT / S&P
PVCT unavailable / 11.88%
LosePVCT / S&P
PVCT unavailable / -17.99%
2022-Q30/3 LosePVCT / S&P
-12.50% / -4.88%
LosePVCT / S&P
PVCT unavailable / 13.47%
LosePVCT / S&P
PVCT unavailable / -1.41%
2022-Q20/3 LosePVCT / S&P
-16.42% / -16.10%
LosePVCT / S&P
PVCT unavailable / 13.71%
LosePVCT / S&P
PVCT unavailable / 11.04%
2022-Q11/3 WinPVCT / S&P
21.82% / -4.60%
LosePVCT / S&P
PVCT unavailable / 15.97%
LosePVCT / S&P
PVCT unavailable / 42.23%
2021-Q40/3 LosePVCT / S&P
-15.38% / 11.03%
LosePVCT / S&P
PVCT unavailable / 15.00%
LosePVCT / S&P
PVCT unavailable / 96.40%
2021-Q30/3 LosePVCT / S&P
-5.80% / 0.58%
LosePVCT / S&P
PVCT unavailable / 10.77%
LosePVCT / S&P
PVCT unavailable / 69.42%
2021-Q20/3 LosePVCT / S&P
1.47% / 8.55%
LosePVCT / S&P
PVCT unavailable / 6.58%
LosePVCT / S&P
PVCT unavailable / 51.81%
2021-Q11/3 WinPVCT / S&P
17.24% / 6.17%
LosePVCT / S&P
PVCT unavailable / -1.06%
LosePVCT / S&P
PVCT unavailable / 7.39%
2020-Q40/3 LosePVCT / S&P
-33.33% / 12.15%
LosePVCT / S&P
PVCT unavailable / -3.72%
LosePVCT / S&P
PVCT unavailable / -33.42%
2020-Q31/3 WinPVCT / S&P
97.73% / 8.93%
LosePVCT / S&P
PVCT unavailable / -2.04%
LosePVCT / S&P
PVCT unavailable / -27.10%
2020-Q20/3 LosePVCT / S&P
-16.98% / 20.54%
LosePVCT / S&P
PVCT unavailable / -0.46%
LosePVCT / S&P
PVCT unavailable / -27.11%
2020-Q11/3 WinPVCT / S&P
-15.87% / -19.60%
LosePVCT / S&P
PVCT unavailable / 3.47%
LosePVCT / S&P
PVCT unavailable / -14.75%
2019-Q40/3 LosePVCT / S&P
-4.55% / 9.07%
LosePVCT / S&P
PVCT unavailable / 5.36%
LosePVCT / S&P
PVCT unavailable / 2.99%
2019-Q31/3 WinPVCT / S&P
4.76% / 1.70%
LosePVCT / S&P
PVCT unavailable / 5.02%
LosePVCT / S&P
PVCT unavailable / 0.21%
2019-Q21/3 WinPVCT / S&P
12.50% / 4.30%
LosePVCT / S&P
PVCT unavailable / 6.64%
LosePVCT / S&P
PVCT unavailable / 8.65%
2019-Q10/3 LosePVCT / S&P
12.00% / 13.65%
LosePVCT / S&P
PVCT unavailable / 8.12%
LosePVCT / S&P
PVCT unavailable / 14.29%
2018-Q40/3 LosePVCT / S&P
-28.57% / -13.52%
LosePVCT / S&P
PVCT unavailable / 9.05%
LosePVCT / S&P
PVCT unavailable / 18.23%
2018-Q30/3 LosePVCT / S&P
-1.41% / 7.71%
LosePVCT / S&P
PVCT unavailable / 10.21%
LosePVCT / S&P
PVCT unavailable / 19.06%
2018-Q21/3 WinPVCT / S&P
10.94% / 3.43%
LosePVCT / S&P
PVCT unavailable / 9.03%
LosePVCT / S&P
PVCT unavailable / 14.46%
2018-Q10/3 LosePVCT / S&P
-21.95% / -0.76%
LosePVCT / S&P
PVCT unavailable / 7.68%
LosePVCT / S&P
PVCT unavailable / 12.46%
2017-Q41/3 WinPVCT / S&P
192.86% / 6.64%
LosePVCT / S&P
PVCT unavailable / 7.03%
LosePVCT / S&P
PVCT unavailable / 13.82%
2017-Q30/3 LosePVCT / S&P
-9.68% / 4.48%
LosePVCT / S&P
PVCT unavailable / 5.68%
LosePVCT / S&P
PVCT unavailable / 17.57%
2017-Q20/3 LosePVCT / S&P
-27.91% / 3.09%
LosePVCT / S&P
PVCT unavailable / 4.83%
LosePVCT / S&P
PVCT unavailable / 17.74%
2017-Q11/3 WinPVCT / S&P
115.00% / 6.07%
LosePVCT / S&P
PVCT unavailable / 3.67%
LosePVCT / S&P
PVCT unavailable / 13.32%
2016-Q40/3 LosePVCT / S&P
-79.80% / 3.82%
LosePVCT / S&P
PVCT unavailable / 2.09%
LosePVCT / S&P
PVCT unavailable / 7.05%
2016-Q30/3 LosePVCT / S&P
-73.24% / 3.85%
LosePVCT / S&P
PVCT unavailable / 0.20%
LosePVCT / S&P
PVCT unavailable / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-27

MetricPVCT total returnS&P 500 Total Return Index
Total return-25.00%20.78%
Annualized return-25.00%20.78%

5Y · 2021-09-01 to 2026-08-27

MetricPVCT total returnS&P 500 Total Return Index
Total return-4.76%83.14%
Annualized return-0.97%12.86%

10Y · 2016-09-01 to 2026-08-27

MetricPVCT total returnS&P 500 Total Return Index
Total return-52.00%319.30%
Annualized return-7.08%15.41%

Calculation rules

window
Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis
Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule
Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency
Quarter endpoints only.
fundamentals
Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.